Thus, the downregulation of DNA-PKcs mediated by miR-145 may be an important beneficial mechanism in radiotherapy for patients with cancer, and therefore, miR-145 may be a new therapeutic target after radiotherapy in human cancer cells. Here, PRKDC is linked to cancer.